proteomics

NanoString loses $31M patent verdict to 10x Genomics

10x Genomics said it plans to seek an injunction that would halt the sales of NanoString's spatial biology products, while NanoString plans to appeal.

Conor Hale Nov 20, 2023 4:15pm

Bruker taps into single-cell biology with $108M PhenomeX deal

Aug 21, 2023 12:55pm

Bruker expands CRO plans with Biognosys majority ownership deal

Jan 4, 2023 3:15pm

Startup Pleno nabs $15M for telecom-based multiomics approach

May 25, 2022 9:00am

To make '1+1=3,' Bayer spends $1.5B for 'undruggables'

Aug 5, 2021 1:30am

SomaLogic to go public with $1.2B valuation in SPAC deal

Apr 2, 2021 10:19am